Pure Global
NCT06393907

Hemostatic Forceps vs. Bipolar Electrocautery Probes for High-Risk Bleeding Gastroduodenal Ulcers

A Randomized Trial of Hemostatic Forceps Versus Bipolar Electrocautery Probes for High-Risk Bleeding Gastroduodenal Ulcers
Mahidol University·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Gastroduodenal Ulcer
Drug/Device/Intervention
Hemostatic Forceps
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Mahidol University
Location
Bangkok Noi, Thailand
Timeline & enrollment
Phase
N/A
Start date
Mar 26, 2024
End date
Apr 26, 2026
Enrollment
150 participants
Primary outcome

Comparing hemostatic rate between hemostatic forceps and bipolar electrocautery probes

Summary

A randomized controlled trial to evaluate the efficacy of hemostatic forceps and bipolar
 electrocautery probes in patient with high risk bleeding gastroduodenal ulcers.

ICD-10 classifications
Gastric ulcerGastrojejunal ulcerGastric ulcer : chronic or unspecified with haemorrhageGastrojejunal ulcer : chronic or unspecified with haemorrhageGastrojejunal ulcer : unspecified as acute or chronic, without haemorrhage or perforation
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06393907
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06393907 through Pure Global AI's free database. This phase not specified trial is sponsored by Mahidol University and is currently Recruiting. The study focuses on Gastroduodenal Ulcer. Target enrollment is 150 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.